Literature DB >> 5779579

Effect of clofibrate on low-density lipoprotein turnover in essential hypercholesterolaemia.

P J Scott, P J Hurley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5779579     DOI： 10.1016/s0368-1319(69)80063-3

Source DB:  PubMed          Journal:  J Atheroscler Res        ISSN： 0368-1319


× No keyword cloud information.
  7 in total

1.  Lipid lowering drugs and coronary heart disease.

Authors:  P J Scott
Journal:  Drugs       Date:  1975       Impact factor: 9.546

Review 2.  A review of studies on the mode of action of clofibrate and betabenzalbutyrate.

Authors:  H J Fallon; L L Adams; R G Lamb
Journal:  Lipids       Date:  1972-02       Impact factor: 1.880

3.  Pharmacological control of lipid transport.

Authors:  R Paoletti; L Puglisi
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1971

4.  Drugs affecting the synthesis of glycerides and phospholipids in rat liver. The effects of clofibrate, halofenate, fenfluramine, amphetamine, cinchocaine, chlorpromazine, demethylimipramine, mepyramine and some of their derivatives.

Authors:  D N Brindley; M Bowley
Journal:  Biochem J       Date:  1975-06       Impact factor: 3.857

5.  Low density lipoprotein degradation by mononuclear cells from normal and dyslipoproteinemic subjects.

Authors:  A M Lees; R S Lees
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

6.  The metabolism of low density lipoprotein in familial type II hyperlipoproteinemia.

Authors:  T Langer; W Strober; R I Levy
Journal:  J Clin Invest       Date:  1972-06       Impact factor: 14.808

7.  The tritium isotope effect of sn-glycerol 3-phosphate oxidase and the effects of clofenapate and N-(2-benzoyloxyethyl)norfenfluramine on the esterification of glycerol phosphate and dihydroxyacetone phosphate by rat liver mitochondria.

Authors:  M Bowley; R Manning; D N Brindlay
Journal:  Biochem J       Date:  1973-10       Impact factor: 3.857
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.